Sign inJoin waitlistJoin the waitlist

Upinder Singh

Infectious Disease · State University of Iowa

Credentials: · · ·

History

University of Virginia College of Medicine
Stanford University School of Medicine
University of Virginia College of Medicine
Ohio State University
1992

Research

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
JAMA · 2023 · 730 citations
The genome of the protist parasite Entamoeba histolytica
Nature · 2005 · 646 citations
New-onset IgG autoantibodies in hospitalized patients with COVID-19
Nature Communications · 2021 · 390 citations

Prasanna Jagannathan
37 papers
Hector Bonilla
18 papers
Jason Andrews
14 papers
Karen Jacobson
14 papers · 3 as a fellow
Catherine Blish
13 papers
Taia Wang
13 papers
Julie Parsonnet
12 papers
Aruna Subramanian
11 papers
Yvonne Maldonado
11 papers
Paul Utz
10 papers
Benjamin Pinsky
9 papers
Kari Nadeau
9 papers

Grants

Long COVID Care Resources and Education to Advance Community Health (REACH)
Agency for Healthcare Research and Quality · U18
Contact PI · $3M · Stanford University
2023–2028
Applied Genomics in Infectious Diseases
National Institute of Allergy and Infectious Diseases · T32
Contact PI · $3.1M · Stanford University
1995–2027
Stanford TRANSFORM I2T Program
National Institute of Allergy and Infectious Diseases · R25
Contact PI · $1.8M · Stanford University
2019–2025
Drug Development Against Entamoeba Histolytica
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $448.1K · Stanford University
2020–2023

Clinical trials

Paxlovid for Treatment of Long Covid
Principal investigator · Completed · Phase 2
Stanford University
2022–2023
COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol
Principal investigator · Completed · Phase 2
Stanford University
2021–2023
Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19
Principal investigator · Completed · Phase 2
Stanford University
2020–2021